Xoma Pharmaceuticals
Xoma (pronounced “zoma”): the most important Petrochem subsidiary, responsible for drug development and production. A world leader in new pharmaceuticals (vaccines and therapies for, among other things, AIDS, schizophrenia and cyberpsychosis), with tightened security and a dark reputation (CP3161 p.18-19). It is also the maker of the stimulant Catch-22 (CP3271 p.75).
Key facts
- Joint programs with Biotechnica: genetic drugs, bacteria and viruses made to order (CP3161 p.19).
- Accused of spreading designer drugs and plagues; no case has gone to court (CP3161 p.19).
- Runs vaccination drives in poor neighborhoods, where it secretly tests designer drugs and plagues; promotes animal welfare to hide experiments (CP3161 p.27).
- Guards: black coveralls, SP 20 vests, helmets with dark visors; Colt Enforcement 10, MustangArms ARS-5C or MustangArms Raider; hired separately and trained by Arasaka Security (CP3161 p.29).
- Headquarters: Xoma Pharmaceuticals Headquarters in South Night City (where the company was founded) (CP3161 p.37).
- Cross-holds 6.2% of Petrochem’s shares, while itself being 100% owned by it (CP3161 p.41).
- Products: Paracaine, Priapan Spray (CP3161 p.33-34).
- Xoma Pharmaceutical is the maker and brand owner of the stimulant Catch-22. (CP3271 p.75)
Relations
- part_of:: Petrochem
- headquarters:: Xoma Pharmaceuticals Headquarters
- ally:: Biotechnica
- manufacturer:: Paracaine
- manufacturer:: Priapan Spray
- related:: Catch-22